Table 2 Demographic characteristics of the healthy controls and patients
From: The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases
Group | Number | Age | Sex |
|---|---|---|---|
Years (IQR) | % male | ||
Healthy controls | 29 | 24 (20-46) | 69 |
Crohn’s disease | 15 | 36 (21-47) | 27 |
Rheumatoid arthritis | 20 | 60 (53-67) | 30 |
Gout | 36 | 68 (54-75) | 83 |
Autoinflammatory syndrome | 15 | 32 (22-42) | 29 |
Pancreatitis | 19 | 64 (58-72) | 80 |
Infectious mononucleosis | 16 | 31 (22-37) | 50 |
Measles | 43 | 7 (3-12) | 43 |
Viral respiratory tract infection | 25 | 29 (17-42) | 52 |
Respiratory co-infections | 20 | 11 (2-49) | 70 |
Bacterial sepsis | 49 | 75 (49-79) | 58 |
Bacterial severe sepsis | 50 | 74 (59-80) | 56 |
Bacterial septic shock | 57 | 72 (60-78) | 56 |
Candidemia | 26 | 59 (41-71) | 69 |